Page 101 - Read Online

Lim et al. Vessel Plus 2021;5:34 https://dx.doi.org/10.20517/2574-1209.2021.44 Page 9 of 9

36. Tsivgoulis G, Katsanos AH, Malhotra K, et al. Thrombolysis for acute ischemic stroke in the unwitnessed or extended therapeutic time
window. Neurology 2020;94:e1241. DOI PubMed
37. Thomalla G, Boutitie F, Ma H, et al; Evaluation of unknown Onset Stroke thrombolysis trials (EOS) investigators. Intravenous
alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual
patient data. Lancet 2020;396:1574-84. DOI PubMed PMC
38. . Stroke Foundation. Clinical Guidelines for Stroke Management.
39. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019
update to the 2018 Guidelines for the early management of acute ischemic stroke: a Guideline for healthcare professionals from the
American Heart Association/American Stroke Association. Stroke 2019;50:e344-418. DOI PubMed
40. Ahmed N, Audebert H, Turc G, et al. Consensus statements and recommendations from the ESO-Karolinska Stroke Update
Conference, Stockholm 11-13 November 2018. Eur Stroke J 2019;4:307-17. DOI PubMed PMC
41. Berge E, Whiteley W, Audebert H, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute
ischaemic stroke. Eur Stroke J 2021;6:I-LXII. DOI PubMed PMC
42. Leira EC, Muir KW. EXTEND trial: towards a more inclusive but complex thrombolysis. Stroke 2019;50:2637-9. DOI PubMed
43. Khatri P, Kleindorfer DO, Devlin T, et al. Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke
and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial. JAMA 2018;320:156-66. DOI PubMed PMC
44. Asdaghi N, Hill MD, Coulter JI, et al. Perfusion MR predicts outcome in high-risk transient ischemic attack/minor stroke: a derivation-
validation study. Stroke 2013;44:2486-92. DOI PubMed
45. Parsons M, Spratt N, Bivard A, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med
2012;366:1099-107. DOI PubMed
46. Campbell BC, Mitchell PJ, Churilov L, et al. Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med
2018;378:1573-82. DOI PubMed
47. Logallo N, Novotny V, Assmus J, et al. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a
phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurol 2017;16:781-8. DOI PubMed
48. Ma H, Wright P, Allport L, et al. Salvage of the PWI/DWI mismatch up to 48 h from stroke onset leads to favorable clinical outcome.
Int J Stroke 2015;10:565-70. DOI PubMed
49. Yang P, Zhang Y, Zhang L, et al; DIRECT-MT Investigators. Endovascular thrombectomy with or without intravenous alteplase in
acute stroke. N Engl J Med 2020;382:1981-93. DOI PubMed
50. Phan TG, Chen J, Donnan G, Srikanth V, Wood A, Reutens DC. Development of a new tool to correlate stroke outcome with infarct
topography: a proof-of-concept study. Neuroimage 2010;49:127-33. DOI PubMed